Paper40539804
Critical amino acid residues in human ACE2 for SARS-CoV-2 spike protein binding and virus entry.
Chen W and 9 others. Microbiol Spectr, 2025. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Critical amino acid residues in human ACE2 for SARS-CoV-2 spike protein binding and virus entry. Papers, record 40539804. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40539804
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Critical amino acid residues in human ACE2 for SARS-CoV-2 spike protein binding and virus entry.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Spike Glycoprotein, Coronavirus | Major topic |
| Angiotensin-Converting Enzyme 2 | Major topic |
| Virus Internalization | Major topic |
| SARS-CoV-2 | Major topic |
| Humans | |
| Amino Acid Substitution | |
| Protein Binding | |
| Molecular Dynamics Simulation | |
| COVID-19 | |
| Mutagenesis, Site-Directed | |
| Receptors, Virus |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| KK2432-10 | Korea Research Institute of Chemical Technology | PubMed | ||
| CAP23011-200 | National Research Council of Science and Technology | PubMed | ||
| RS-2024-00344154 | National Research Foundation of Korea | PubMed |
Source PubMed
References88
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33580154 | Human ACE2 peptide-mimics block SARS-CoV-2 pulmonary cells infection. | Commun Biol | 2021 | https://conductscience.org/library/papers/33580154 | PubMed |
| 2 | 32747721 | Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. | Acta Pharmacol Sin | 2020 | https://conductscience.org/library/papers/32747721 | PubMed |
| 3 | 33892621 | SARS-CoV-2 in animals: potential for unknown reservoir hosts and public health implications. | Vet Q | 2021 | https://conductscience.org/library/papers/33892621 | PubMed |
| 4 | 34139177 | Binding and molecular basis of the bat coronavirus RaTG13 virus to ACE2 in humans and other species. | Cell | 2021 | https://conductscience.org/library/papers/34139177 | PubMed |
| 5 | 36652990 | Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population. | Nat Med | 2023 | https://conductscience.org/library/papers/36652990 | PubMed |
| 6 | 32755673 | SARS-CoV-2 jumping the species barrier: Zoonotic lessons from SARS, MERS and recent advances to combat this pandemic virus. | Travel Med Infect Dis | 2020 | https://conductscience.org/library/papers/32755673 | PubMed |
| 7 | 36689489 | Effect of polymorphism in Rhinolophus affinis ACE2 on entry of SARS-CoV-2 related bat coronaviruses. | PLoS Pathog | 2023 | https://conductscience.org/library/papers/36689489 | PubMed |
| 8 | 32847856 | SARS-CoV-2 and Three Related Coronaviruses Utilize Multiple ACE2 Orthologs and Are Potently Blocked by an Improved ACE2-Ig. | J Virol | 2020 | https://conductscience.org/library/papers/32847856 | PubMed |
| 9 | 37954960 | Exploring the disruption of SARS-CoV-2 RBD binding to hACE2. | Front Chem | 2023 | https://conductscience.org/library/papers/37954960 | PubMed |
| 10 | 34582502 | Identifying key determinants and dynamics of SARS-CoV-2/ACE2 tight interaction. | PLoS One | 2021 | https://conductscience.org/library/papers/34582502 | PubMed |
| 11 | 38442025 | Mutations in the SARS-CoV-2 spike receptor binding domain and their delicate balance between ACE2 affinity and antibody evasion. | Protein Cell | 2024 | https://conductscience.org/library/papers/38442025 | PubMed |
| 12 | 36163676 | SARS-CoV-2 infection in dogs and cats is associated with contact to COVID-19-positive household members. | Transbound Emerg Dis | 2022 | https://conductscience.org/library/papers/36163676 | PubMed |
| 13 | 32201080 | Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection. | Biochem Biophys Res Commun | 2020 | https://conductscience.org/library/papers/32201080 | PubMed |
| 14 | 33846513 | Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2. | Commun Biol | 2021 | https://conductscience.org/library/papers/33846513 | PubMed |
| 15 | 33285566 | Key residues influencing binding affinities of 2019-nCoV with ACE2 in different species. | Brief Bioinform | 2021 | https://conductscience.org/library/papers/33285566 | PubMed |
| 16 | 16510163 | Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor. | Virology | 2006 | https://conductscience.org/library/papers/16510163 | PubMed |
| 17 | 34818667 | The N501Y spike substitution enhances SARS-CoV-2 infection and transmission. | Nature | 2022 | https://conductscience.org/library/papers/34818667 | PubMed |
| 18 | 34428371 | Key Interacting Residues between RBD of SARS-CoV-2 and ACE2 Receptor: Combination of Molecular Dynamics Simulation and Density Functional Calculation. | J Chem Inf Model | 2021 | https://conductscience.org/library/papers/34428371 | PubMed |
| 19 | 32362314 | A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells. | Mol Cell | 2020 | https://conductscience.org/library/papers/32362314 | PubMed |
| 20 | 33189768 | Peptide and peptide-based inhibitors of SARS-CoV-2 entry. | Adv Drug Deliv Rev | 2020 | https://conductscience.org/library/papers/33189768 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42198738 | Bat-Borne Viruses and Pandemic Risk: Could Europe Be an Emergence Hotspot? | Viruses | 2026 | https://conductscience.org/library/papers/42198738 | PubMed |
| 41615206 | Computational and experimental identification of potential neutralizing peptides derived from human ACE2 against SARS-CoV-2 infection. | J Virol | 2026 | https://conductscience.org/library/papers/41615206 | PubMed |
| 41097380 | Computational Discovery of Potent Nucleoprotein Inhibitors for Influenza A Virus: Validation Through QM/MM Analysis and Experimental Binding Assays. | Molecules | 2025 | https://conductscience.org/library/papers/41097380 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ACE2 | 59272 | PubTator's text mining | https://conductscience.org/library/genes/59272 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40539804
GET https://conductscience.org/api/papers/v1/40539804/references?page=2